| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC0867 |
| Trial ID | ChiCTR2000033935 |
| Disease | Hematologic Cancer |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | NY-ESO-1 TCR-T cells |
| HLA | HLA-A*02 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | NY-ESO-1 TCR-T cell therapy for relapse or refractory Hematological malignancies |
| Year | 2020 |
| Country | China |
| Company sponsor | Tianjin First Central Hospital |
| Cohort 1 | |||||||
|
|||||||